PLK1-IN-14

Product Specifications

Target

PLK

Related Pathways

Cell Cycle/Checkpoint

Bioactivity

PLK1-IN-14 (Compound Hit-4) is a selective PLK1 inhibitor with an IC50 of 22.61 pM for PLK1, and an IC50 of 0.09 nM for inhibiting the proliferation of DU-145 prostate cancer cells. It is applicable in prostate cancer research.

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

K1013001 3x 1.0 µg

IDDM4 sgRNA CRISPR Lentivector set (Human)

View Details

PC1023096 1 Each

2-Bromo-4-ethoxy-1-fluorobenzene

View Details

GTR10442632 96 Well

Mouse CAP Gly domain containing linker protein 3 (CLIP3) ELISA kit

View Details

MR222897L4 10 µg

Adrbk2 (NM_001035531) Mouse Tagged Lenti ORF Clone

View Details

BG-RAT11755 1 Each

Rat Platelet Derived Growth Factor C PDGFC ELISA Kit

View Details

040836-HRP 200 µL

RARA, CT (RARA, NR1B1, Retinoic acid receptor alpha, Nuclear receptor subfamily 1 group B member 1) (Azide free) (HRP) discontinued

View Details